Reinier Raymakers

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt et al. · Journal of Clinical Oncology · 2012 · 819 citations · Full text

Acquired mutations in TET2 are common in myelodysplastic syndromes

Saskia Langemeijer, Roland P. Kuiper, M Berends et al. · Nature Genetics · 2009 · 740 citations

Hematological Malignancy, Genetic Disorder, Medicine +6

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

Régis Peffault de Latour, Austin Kulasekararaj, Simona Iacobelli et al. · New England Journal of Medicine · 2022 · 265 citations · Full text

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis

Rick Admiraal, Stefan Nierkens, Moniek A. de Witte et al. · The Lancet Haematology · 2017 · 209 citations · Full text

Survival Outcomes, Transplantation, Autoimmune Disease +14

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

Hartmut Goldschmidt, H M Lokhorst, E K et al. · Leukemia · 2017 · 197 citations · Full text

Hematological Malignancy, Oncology, Hematology +7